Filing Details
- Accession Number:
- 0001483813-12-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-29 19:15:45
- Reporting Period:
- 2012-11-29
- Filing Date:
- 2012-11-29
- Accepted Time:
- 2012-11-29 19:15:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1078452 | Robert Engler | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-29 | 15,000 | $5.57 | 165,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
